Tenet Healthcare (THC) Tops Q3 EPS by 58c; offers guidance

Tenet Healthcare (NYSE: THC) reported Q3 EPS of $2.93, $0.58 better than the analyst estimate of $2.35. Revenue for the quarter came in at $5.12 billion versus the consensus estimate of $5.05 billion.

GUIDANCE:

Tenet Healthcare sees Q4 2024 EPS of $2.69-$3.31, versus the consensus of $2.90. Tenet Healthcare sees Q4 2024 revenue of $5.01-5.21 billion, versus the consensus of $5.28 billion.

Tenet Healthcare sees FY2024 EPS of $11.12-$11.73, versus the consensus of $10.74. Tenet Healthcare sees FY2024 revenue of $20.6-20.8 billion, versus the consensus of $20.82 billion.

For earnings history and earnings-related data on Tenet Healthcare (THC) click here.

You May Also Be Interested In

• Phibro Animal Health (PAHC) Tops Q1 EPS by 2c; Offers Guidance
• Lemaitre Vascular (LMAT) Misses Q3 EPS by 4c ; Offers Guidance
• Ingevity (NGVT) Tops Q3 EPS by 7c, Beats on Revenue; Offers FY26 EPS Guidance